Thursday, 24 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14475
Articles
Company
Drug
Salubris Pharmaceuticals’ SAL0119 Accepted for CDE Review in China
January 30, 2025
Company
Drug
Aosaikang’s ASKG915 Accepted for FDA Review, Targets Advanced Solid Tumors
January 30, 2025
Company
Drug
Legend Biotech Receives IND Approval for LB2102 CAR-T Therapy
January 30, 2025
Company
Drug
Sun-Novo Pharma Gains NMPA Approval for STC007 Clinical Study in CKD-aP
January 30, 2025
Company
Deals
JD Healthcare Partners with Jiangsu Yuyue for Medical Device Collaboration
January 30, 2025
Company
Drug
Junshi Biosciences’ JunMaiKang Approved by NMPA for Multiple Indications
January 30, 2025
Company
Drug
Hengrui Pharmaceuticals Receives FDA ANDA Approval for Gadobutrol Generic
January 30, 2025
Company
Drug
Fosun Pharma’s Bivalent COVID-19 Vaccine Comirnaty Authorized in Hong Kong
January 30, 2025
Company
Drug
IASO Biotherapeutics Reports Positive Phase I Results for CAR-T Therapy in NMOSD
January 30, 2025
Company
Deals
ViVest Medical Raises Funds for Wearable Cardioverter Defibrillator Development
January 30, 2025
Company
Drug
Mabwell Receives Approval for Clinical Study of 9MW3011 in Polycythemia Vera
January 30, 2025
Policy / Regulatory
China’s CDE, HNMPA, and Bo’ao Lecheng Release Real-world Drug Research Measures
January 30, 2025
1
2
…
1,092
1,093
1,094
1,095
1,096
…
1,206
1,207
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?